article Open AccessTop 1% cited
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
Nature Genetics · 2009 · Vol. 41(10) · pp. 1094–1099
the European Alzheimer's Disease Initiative Investigators✉(Inserm)Jean‐Charles Lambert(Inserm)Simon Heath(Inserm)Gaël Even(Inserm)Dominique Campion(VIB-UAntwerp Center for Molecular Neurology)Kristel Sleegers(Helmholtz Zentrum München)Mikko Hiltunen(Universidad de Cantabria)Onofre CombarrosDiana Zélénika(Consejo Superior de Investigaciones Científicas)María J. Bullido(CHU Dijon Bourgogne)Béatrice Tavernier(Inserm)Luc Letenneur(VIB-UAntwerp Center for Molecular Neurology)Karolien Bettens(Inserm)Claudine Berr(Université de Lille)Florence Pasquier(Institut Pasteur de Lille)Nathalie Fiévet(Inserm)Pascale Barberger‐Gateau(University of Antwerp)Sebastiaan Engelborghs(University of Antwerp)Peter Paul De Deyn(Universidad de Cantabria)Ignacio Mateo(Hospital Universitario La Paz)A. Franck(Kuopio University Hospital)Seppo Helisalmi(University of Bologna)Elisa Porcellini(Délégation Paris 5)Olivier Hanon(University of the Basque Country)Marian M. de Pancorbo(QIMR Berghofer Medical Research Institute)Corinne Lendon(Inserm)Carole Dufouil(Institut de la Vision)Céline Jaillard(Institut de la Vision)Thierry Léveillard(Hospital Universitario Central de Asturias)Victoria Álvarez(Oasi Maria SS)Paolo Bosco(University of Pisa)Michelangelo Mancuso(University of Bari Aldo Moro)Francesco PanzaBenedetta Nacmias(Fondazione Santa Lucia)Paola Bossù(University of Cagliari)Paola Piccardi(University of Milano-Bicocca)Giorgio Annoni(Casa Sollievo della Sofferenza)Davide Seripa(University of Milan)Daniela Galimberti(Inserm)Didier Hannequin(University of Bologna)Federico Licastro(Kuopio University Hospital)Hilkka Soininen(Inserm)Karen Ritchie(Fondation Jean Dausset-CEPH)Hélène Blanché(Inserm)Jean‐François Dartigues(Inserm)Christophe TzourioMarta Gut(University of Antwerp)Christine Van Broeckhoven(Inserm)Annick Alpérovitch(Fondation Jean Dausset-CEPH)Mark Lathrop(Centre Hospitalier Universitaire de Lille)Philippe Amouyel
Alzheimer's disease research and treatmentsBioinformatics and Genomic NetworksGenetic Associations and EpidemiologyClusterinComplement receptor 1Apolipoprotein EBiologyGenome-wide association studyDiseaseAlzheimer's diseaseGenetic associationGeneticsLocus (genetics)
Funding
- U.S. Department of Health and Human Services
- Juvenile Diabetes Research Foundation International
- Wellcome Trust
- Alzheimer's Society
- Alzheimer's Research Trust
- Motor Neurone Disease Association
- University College London
- Cardiff University
- Bundesministerium für Bildung und Forschung
- Belgian Federal Science Policy Office
- Alfried Krupp von Bohlen und Halbach-Stiftung
- Universiteit Antwerpen
- Vlaamse regering
- H. Lundbeck A/S
- Instituut Born-Bunge
- Heinz Nixdorf Stiftung
- National Institutes of Health
- Medical Research Council
- Bijzonder Onderzoeksfonds UGent
- Helmholtz Zentrum München
- National Institute on Aging
- National Institute of Allergy and Infectious Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Child Health and Human Development
Citations
2,256
FWCI
86.21
field-weighted impact
References
41
Percentile
100%
vs. same field & year
Citations per year
Cited by
Alzheimer’s Disease: The Challenge of the Second Century
Science Translational Medicine · 2011 · 1,414 citations
Blood-Brain Barrier: From Physiology to Disease and Back
Physiological Reviews · 2018 · 2,072 citations
Microglia: Agents of the CNS Pro-Inflammatory Response
Cells · 2020 · 348 citations
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Nature Reviews Drug Discovery · 2011 · 2,182 citations
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Biological Psychiatry · 2014 · 1,338 citations
Defeating Alzheimer's disease and other dementias: a priority for European science and society
The Lancet Neurology · 2016 · 1,667 citations
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Biochemical Pharmacology · 2014 · 1,164 citations
Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
Frontiers in Neuroscience · 2019 · 377 citations
References
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease
JAMA · 1997 · 4,580 citations
Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System
Journal of Cerebral Blood Flow & Metabolism · 2006 · 667 citations
Early-Onset Autosomal Dominant Alzheimer Disease: Prevalence, Genetic Heterogeneity, and Mutation Spectrum
The American Journal of Human Genetics · 1999 · 786 citations
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
Science · 2002 · 13,715 citations
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Nature Genetics · 2009 · 3,381 citations
Principal components analysis corrects for stratification in genome-wide association studies
Nature Genetics · 2006 · 10,603 citations
Haploview: analysis and visualization of LD and haplotype maps
Bioinformatics · 2004 · 14,661 citations
Role of Genes and Environments for Explaining Alzheimer Disease
Archives of General Psychiatry · 2006 · 1,839 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.